We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company through a range of means, it has emerged.